EGFR and non-small cell lung carcinoma: For elucidating the mode of resistance to Osimertinib in the EGFR-wild type H358 and EGFR-mutant H1975 NSCLC cell lines, immunoblotting was performed to determine the varying levels of EMT-related proteins.